Published in PLoS One on April 20, 2010
Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells. Proc Natl Acad Sci U S A (2013) 1.26
ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling. Nat Cell Biol (2014) 1.19
A boost for the emerging field of RNA nanotechnology. ACS Nano (2011) 1.17
Next-generation libraries for robust RNA interference-based genome-wide screens. Proc Natl Acad Sci U S A (2015) 1.08
Designing highly active siRNAs for therapeutic applications. FEBS J (2010) 1.01
Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line. Int J Cancer (2013) 0.94
Improved siRNA/shRNA functionality by mismatched duplex. PLoS One (2011) 0.89
Efficient downregulation of multiple mRNA targets with a single shRNA-expressing lentiviral vector. Plasmid (2010) 0.87
Optimized models for design of efficient miR30-based shRNAs. Front Genet (2012) 0.86
Accelerating cancer modeling with RNAi and nongermline genetically engineered mouse models. Cold Spring Harb Protoc (2013) 0.80
Optimization of Critical Hairpin Features Allows miRNA-based Gene Knockdown Upon Single-copy Transduction. Mol Ther Nucleic Acids (2014) 0.79
Molecular Properties, Functional Mechanisms, and Applications of Sliced siRNA. Mol Ther Nucleic Acids (2015) 0.78
Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targeting. Nucleic Acid Ther (2011) 0.76
Enhancing potency of siRNA targeting fusion genes by optimization outside of target sequence. Proc Natl Acad Sci U S A (2015) 0.75
Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen. Sci Rep (2017) 0.75
Mini-clusters with mean probabilities for identifying effective siRNAs. BMC Res Notes (2012) 0.75
Molecular genetic mechanisms of allelic specific regulation of murine Comt expression. Pain (2015) 0.75
A system for stable expression of short interfering RNAs in mammalian cells. Science (2002) 35.21
Asymmetry in the assembly of the RNAi enzyme complex. Cell (2003) 22.18
Functional siRNAs and miRNAs exhibit strand bias. Cell (2003) 19.15
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev (2002) 10.71
Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson-Crick base pairs. Biochemistry (1998) 9.75
Design of a genome-wide siRNA library using an artificial neural network. Nat Biotechnol (2005) 5.60
Cancer proliferation gene discovery through functional genomics. Science (2008) 5.41
Ribonuclease A. Chem Rev (1998) 4.72
Profiling essential genes in human mammary cells by multiplex RNAi screening. Science (2008) 4.51
Synthetic shRNAs as potent RNAi triggers. Nat Biotechnol (2004) 3.67
Off-target effects by siRNA can induce toxic phenotype. RNA (2006) 2.89
Predicting oligonucleotide affinity to nucleic acid targets. RNA (1999) 2.67
The impact of target site accessibility on the design of effective siRNAs. Nat Biotechnol (2008) 2.51
The contributions of dsRNA structure to Dicer specificity and efficiency. RNA (2005) 2.48
A periodic pattern of mRNA secondary structure created by the genetic code. Nucleic Acids Res (2006) 2.24
Origins and evolution of eukaryotic RNA interference. Trends Ecol Evol (2008) 2.15
A comparison of siRNA efficacy predictors. Biochem Biophys Res Commun (2004) 1.78
Effect of target secondary structure on RNAi efficiency. RNA (2007) 1.76
Computational models with thermodynamic and composition features improve siRNA design. BMC Bioinformatics (2006) 1.69
Efficient siRNA selection using hybridization thermodynamics. Nucleic Acids Res (2007) 1.68
Comparison of approaches for rational siRNA design leading to a new efficient and transparent method. Nucleic Acids Res (2007) 1.68
Criteria for effective design, construction, and gene knockdown by shRNA vectors. BMC Biotechnol (2006) 1.60
Sequence characteristics of functional siRNAs. RNA (2005) 1.59
Beginning to understand microRNA function. Cell Res (2007) 1.59
Specific residues at every third position of siRNA shape its efficient RNAi activity. Nucleic Acids Res (2007) 1.49
A protocol for designing siRNAs with high functionality and specificity. Nat Protoc (2007) 1.49
Defining the optimal parameters for hairpin-based knockdown constructs. RNA (2007) 1.48
Classification of common conserved sequences in mammalian intergenic regions. Hum Mol Genet (2002) 1.31
Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities. Nucleic Acids Res (2007) 1.22
Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans. DNA Cell Biol (1997) 1.22
More complete gene silencing by fewer siRNAs: transparent optimized design and biophysical signature. Nucleic Acids Res (2006) 1.18
Induction of stable RNA interference in mammalian cells. Gene Ther (2006) 1.15
Integrated siRNA design based on surveying of features associated with high RNAi effectiveness. BMC Bioinformatics (2006) 1.15
Analysis of internal loops within the RNA secondary structure in almost quadratic time. Bioinformatics (2006) 1.13
Filtering of ineffective siRNAs and improved siRNA design tool. Bioinformatics (2004) 1.10
Demonstration of two novel methods for predicting functional siRNA efficiency. BMC Bioinformatics (2006) 0.99
RFRCDB-siRNA: improved design of siRNAs by random forest regression model coupled with database searching. Comput Methods Programs Biomed (2007) 0.93
Selecting effective siRNA sequences by using radial basis function network and decision tree learning. BMC Bioinformatics (2006) 0.87
A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct (2006) 11.31
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem (2008) 10.08
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest (2005) 6.10
Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87
MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell (2009) 4.47
MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A (2008) 4.16
E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell (2002) 3.87
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med (2011) 3.82
Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res (2007) 3.63
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest (2012) 3.45
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell (2011) 3.32
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell (2011) 3.23
Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res (2010) 2.88
MicroRNAs in disease and potential therapeutic applications. Mol Ther (2007) 2.73
Tumor metastasis: moving new biological insights into the clinic. Nat Med (2013) 2.71
Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer (2011) 2.64
Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. Science (2010) 2.62
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev (2009) 2.59
The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol (2009) 2.56
Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat Cell Biol (2012) 2.46
Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell (2012) 2.39
A periodic pattern of mRNA secondary structure created by the genetic code. Nucleic Acids Res (2006) 2.24
Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat Med (2009) 2.10
Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Mol Cell (2002) 2.05
Abundance of type I toxin-antitoxin systems in bacteria: searches for new candidates and discovery of novel families. Nucleic Acids Res (2010) 1.93
The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res (2009) 1.89
Selection in favor of nucleotides G and C diversifies evolution rates and levels of polymorphism at mammalian synonymous sites. J Theor Biol (2005) 1.88
Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes. Mol Cell Biol (2002) 1.86
Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem (2009) 1.81
Purifying and directional selection in overlapping prokaryotic genes. Trends Genet (2002) 1.74
Computational models with thermodynamic and composition features improve siRNA design. BMC Bioinformatics (2006) 1.69
Comparison of approaches for rational siRNA design leading to a new efficient and transparent method. Nucleic Acids Res (2007) 1.68
Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell (2013) 1.62
OWEN: aligning long collinear regions of genomes. Bioinformatics (2002) 1.60
Reliable prediction of Drosha processing sites improves microRNA gene prediction. Bioinformatics (2006) 1.59
Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet (2008) 1.59
Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis. J Biol Chem (2012) 1.58
Congruent evolution of different classes of non-coding DNA in prokaryotic genomes. Nucleic Acids Res (2002) 1.54
Cell fusion as a hidden force in tumor progression. Cancer Res (2009) 1.51
Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet (2006) 1.50
Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia (2007) 1.49
Comparative analysis of orthologous eukaryotic mRNAs: potential hidden functional signals. Nucleic Acids Res (2004) 1.49
Genetic architecture of human pain perception. Trends Genet (2007) 1.48
Viruses with more than 1,000 genes: Mamavirus, a new Acanthamoeba polyphaga mimivirus strain, and reannotation of Mimivirus genes. Genome Biol Evol (2011) 1.47
Weighted sequence motifs as an improved seeding step in microRNA target prediction algorithms. RNA (2005) 1.46
Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis. Mol Cancer (2010) 1.45
Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc Natl Acad Sci U S A (2009) 1.45
Analysis of similarity within 142 pairs of orthologous intergenic regions of Caenorhabditis elegans and Caenorhabditis briggsae. Nucleic Acids Res (2002) 1.44
Calibrating E-values for MS2 database search methods. Biol Direct (2007) 1.44
Positive selection at sites of multiple amino acid replacements since rat-mouse divergence. Nature (2004) 1.40
Related giant viruses in distant locations and different habitats: Acanthamoeba polyphaga moumouvirus represents a third lineage of the Mimiviridae that is close to the megavirus lineage. Genome Biol Evol (2012) 1.40
The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) (2013) 1.40
A significant fraction of conserved noncoding DNA in human and mouse consists of predicted matrix attachment regions. Trends Genet (2003) 1.39
Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. Stem Cells (2012) 1.37
Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. J Biol Chem (2010) 1.36
Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. J Biol Chem (2011) 1.33
Classification of common conserved sequences in mammalian intergenic regions. Hum Mol Genet (2002) 1.31
In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer. Cancer Res (2010) 1.31
Evolution of alternative and constitutive regions of mammalian 5'UTRs. BMC Genomics (2009) 1.31
Targeting the transforming growth factor-beta signalling pathway in metastatic cancer. Eur J Cancer (2010) 1.27
RAId_DbS: peptide identification using database searches with realistic statistics. Biol Direct (2007) 1.27
A role for the Dicer helicase domain in the processing of thermodynamically unstable hairpin RNAs. Nucleic Acids Res (2008) 1.25
Continuing evolution of Burkholderia mallei through genome reduction and large-scale rearrangements. Genome Biol Evol (2010) 1.24
Bioinformatical assay of human gene morbidity. Nucleic Acids Res (2004) 1.23
Negative correlation between expression level and evolutionary rate of long intergenic noncoding RNAs. Genome Biol Evol (2011) 1.23
MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J Transl Med (2011) 1.22
EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. J Biol Chem (2007) 1.22
Global secretome analysis identifies novel mediators of bone metastasis. Cell Res (2012) 1.22
Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation. BMC Bioinformatics (2008) 1.19
Widespread positive selection in synonymous sites of mammalian genes. Mol Biol Evol (2007) 1.17
Association of polymorphisms in odorant-binding protein genes with variation in olfactory response to benzaldehyde in Drosophila. Genetics (2007) 1.17
Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Autophagy (2014) 1.14
Analysis of internal loops within the RNA secondary structure in almost quadratic time. Bioinformatics (2006) 1.13
From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Res (2011) 1.12
Distinct patterns of expression and evolution of intronless and intron-containing mammalian genes. Mol Biol Evol (2010) 1.11
Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation. Nat Commun (2013) 1.08
SnapShot: Bone Metastasis. Cell (2012) 1.07
A quantitative atlas of histone modification signatures from human cancer cells. Epigenetics Chromatin (2013) 1.06
Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. Clin Breast Cancer (2011) 1.03
Distant conserved sequences flanking endothelial-specific promoters contain tissue-specific DNase-hypersensitive sites and over-represented motifs. Hum Mol Genet (2006) 1.00
Dysregulation of developmental pathways in bone metastasis. Bone (2010) 0.99
Disruptive mRNA folding increases translational efficiency of catechol-O-methyltransferase variant. Nucleic Acids Res (2011) 0.99
Rabconnectin-3 is a functional regulator of mammalian Notch signaling. J Biol Chem (2010) 0.98
Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo. J Bone Miner Res (2011) 0.97
MiR-215 modulates gastric cancer cell proliferation by targeting RB1. Cancer Lett (2013) 0.97
Patterns in interspecies similarity correlate with nucleotide composition in mammalian 3'UTRs. Nucleic Acids Res (2003) 0.96
Metadherin as a link between metastasis and chemoresistance. Cell Cycle (2009) 0.95
Bone metastases detection by circulating biomarkers: OPG and RANK-L. Int J Oncol (2011) 0.95
RAId_DbS: mass-spectrometry based peptide identification web server with knowledge integration. BMC Genomics (2008) 0.95
The crystal structure and mutational analysis of a novel RNA-binding domain found in the human Tap nuclear mRNA export factor. Proc Natl Acad Sci U S A (2002) 0.94
Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line. Int J Cancer (2013) 0.94
The endoplasmic reticulum acts as a platform for ubiquitylated components of nuclear factor κB signaling. Sci Signal (2013) 0.94